Free Trial

Prime Capital Investment Advisors LLC Trims Position in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Prime Capital Investment Advisors LLC lessened its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 21.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 24,381 shares of the company's stock after selling 6,620 shares during the quarter. Prime Capital Investment Advisors LLC's holdings in Colgate-Palmolive were worth $2,531,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Savvy Advisors Inc. grew its stake in shares of Colgate-Palmolive by 28.4% during the 3rd quarter. Savvy Advisors Inc. now owns 3,319 shares of the company's stock valued at $345,000 after buying an additional 735 shares during the period. Winslow Asset Management Inc. acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $415,000. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Colgate-Palmolive by 1.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,989,776 shares of the company's stock worth $206,559,000 after purchasing an additional 23,099 shares during the period. Harbour Investments Inc. grew its position in Colgate-Palmolive by 7.1% in the 3rd quarter. Harbour Investments Inc. now owns 9,836 shares of the company's stock valued at $1,021,000 after buying an additional 650 shares in the last quarter. Finally, Entropy Technologies LP bought a new stake in Colgate-Palmolive during the third quarter worth approximately $5,638,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on CL shares. Barclays boosted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an "equal weight" rating in a report on Monday, July 29th. TD Cowen decreased their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, October 28th. Evercore ISI lifted their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an "outperform" rating in a research note on Thursday, July 18th. Hsbc Global Res cut Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 26th. Finally, Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their target price for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $105.11.

Get Our Latest Analysis on Colgate-Palmolive

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.34% of the company's stock.

Colgate-Palmolive Trading Up 0.3 %

NYSE:CL traded up $0.23 during trading hours on Thursday, hitting $91.30. 2,939,317 shares of the company were exchanged, compared to its average volume of 4,366,512. The stock has a market capitalization of $74.59 billion, a price-to-earnings ratio of 26.10, a price-to-earnings-growth ratio of 3.27 and a beta of 0.42. The company has a fifty day simple moving average of $99.94 and a 200 day simple moving average of $98.48. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines